Vertex Pharmaceuticals (VRTX)

$399.92 0.00 (0.00%)

16:00 EDT VRTX Stock Quote Delayed 30 Minutes

3 Biotech Stocks Set to Double by 2028

By Terel Miles, InvestorPlace Contributor Apr 20, 2024

These are three of the top biotech stocks set to double by 2028. Add them to your portfolio to maximize your potential gains.

The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

3 Underappreciated Healthcare Stocks to Buy Now: April 2024

Volume:

Previous Close -

Market Cap 103.75B

PE Ratio 28.79

EPS 13.89

Volume (Avg. Vol.) 8

Day's Range -

52-Week Range $316.43 - $448.40

Dividend & Yield N/A (N/A)

VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News

From InvestorPlace
From the Web

3 Biotech Stocks to Buy for the Next Bull Run: March 2024

By Mohammed Saqib, InvestorPlace Contributor Mar 26, 2024

These biotech stocks to buy are well positioned for growth, and will generate solid returns for investors in the next bull run.

3 Biopharma Stocks Predicted to Soar in Q2 2024

By Joel Lim, InvestorPlace Contributor Mar 20, 2024

These biopharma stocks can produce massive returns for Q2 based on new product releases and international treatment approvals.

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

By Muslim Farooque, InvestorPlace Contributor Mar 19, 2024

These biotech stocks to buy offer a gateway to long-term gains, on the back of groundbreaking healthcare innovations.

The Top 3 Biotech Stocks to Buy in March 2024

By Chris Markoch, InvestorPlace Contributor Mar 6, 2024

Although the biotech sector puts the benefits and risks in plain sight, three top biotech stocks to buy shine for investors.

Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making

By Terel Miles, InvestorPlace Contributor Mar 5, 2024

These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.

Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits

By Will Ashworth, InvestorPlace Contributor Mar 4, 2024

Given recent industry performance, the enthusiasm investors have for biotech stocks to buy is low. But these three companies seem promising.

ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential

By Viktor Zarev, InvestorPlace Contributor Mar 4, 2024

Here are three ChatGPT stock predictions for the most unpredictable of biotech stocks that might just have 10x potential.

3 Biotech Stocks Bound to Blast Off By 2029

By Chandler Capital, InvestorPlace Contributor Feb 27, 2024

Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.

3 Secret Stocks to Double Your Money by 2028

By Terel Miles, InvestorPlace Contributor Feb 22, 2024

Vertex Pharmaceuticals (VRTX), UiPath (PATH), and Science Applications International (SAIC) are 3 secret stocks to double your money by 2028.

3 Revolutionary Biotech Stocks Poised for 10X Surge

By Muslim Farooque, InvestorPlace Contributor Feb 19, 2024

Discover three biotech stocks set to soar in a $3.08 trillion market, merging medical innovations with financial growth opportunities.

3 Groundbreaking Healthcare Stocks to Buy for Robust Gains

By Faizan Farooque, InvestorPlace Contributor Feb 11, 2024

The health sector has two things to offer: new ideas and consistent returns. As a result, healthcare stocks will continue to be a good choice…

Cooling Off? 3 Popular Stocks With Recent Target Cuts

By Tezcan Gecgil, InvestorPlace Contributor Feb 11, 2024

Popular stocks with slashed price targets: opportunity or warning sign? Dive into the analysis behind 3 recent downgrades.

3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List

By Jeremy Flint, InvestorPlace Contributor Feb 9, 2024

These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.

The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024

By Muslim Farooque, InvestorPlace Contributor Feb 6, 2024

Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements

Top Stock Picks 2024: 3 Healthcare Stocks Leading Medical Advancements

By Faizan Farooque, InvestorPlace Contributor Feb 1, 2024

Your ultimate guide to investing in healthcare stocks in 2024. Learn about the most promising healthcare companies, market forecasts, and investment strategies tailored for you.

Buy Alert: 3 Stocks Sitting in the Sweet Spot

By Chandler Capital, InvestorPlace Contributor Jan 31, 2024

They say timing is everything, so investors will want to take advantage of buying these stocks now instead of waiting.

Biotech Stocks Are on Fire: Here Are the Top 3 Picks for January

By Chandler Capital, InvestorPlace Contributor Jan 25, 2024

These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.

3 Must-Buy Healthcare Stocks for a Healthy 2024

By Terel Miles, InvestorPlace Contributor Jan 22, 2024

The best healthcare stocks to buy for a healthy 2024 include these 3 companies that have shown stability and growth.

Gen Z’s Top Picks for 2024: 7 Trending Stocks Among Young Investors

By Jeremy Flint, InvestorPlace Contributor Jan 4, 2024

Gen Z stocks include companies the generation prefers to invest in while capturing the emerging economic force they represent.

3 Healthcare Stocks to Make You the Millionaire Next Door: 2024 Edition

By Jeremy Flint, InvestorPlace Contributor Jan 3, 2024

Healthcare stocks tend to be more mature and reliable, but a handful of innovators offer massive long-term upside.

Vertex Pharmaceuticals (VRTX)

3 Biotech Stocks Set to Double by 2028

The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April

3 Underappreciated Healthcare Stocks to Buy Now: April 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Vertex Pharmaceuticals (VRTX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VRTX Stock Predictions, Articles, and Vertex Pharmaceuticals News

Subscriber Sign in